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The Journal of Immunology
Altered Distribution and Increased IL-17 Production by
Mucosal-Associated Invariant T Cells in Adult and
Childhood Obesity
Eirin Carolan,*,†,1 Laura M. Tobin,*,1 Bozgana A. Mangan,‡,1 Michelle Corrigan,*
Gadinthsware Gaoatswe,* Greg Byrne,x Justin Geoghegan,* Declan Cody,{
Jean O’Connell,* Desmond C. Winter,* Derek G. Doherty,‡ Lydia Lynch,‖
Donal O’Shea,*,2 and Andrew E. Hogan*,†,2
Mucosal-associated invariant T (MAIT) cells are innate MHC-unrestricted cells that regulate inflammatory responses through the rapid
production of cytokines. In this article, we show that circulating MAIT cells are depleted in obese adults, and depletion is associated with
diabetic status. Circulating MAIT cells more frequently produced IL-17 upon stimulation ex vivo, a cytokine implicated in insulin re-
sistance. MAIT cells were enriched in adipose tissue (AT) compared with blood. AT MAIT cells, but not circulating MAIT cells, were
capable of producing IL-10. In AT from obese subjects, MAIT cells were depleted, were less likely to produce IL-10, and more frequently
produced IL-17. Finally, we show that IL-17+ MAIT cells are also increased in childhood obesity, and altered MAIT cell frequencies in
obese children are positively associated with insulin resistance. These data indicate that MAIT cells are enriched in human AT and
display an IL-17+ phenotype in both obese adults and children, correlating with levels of insulin resistance. The alterations in MAIT cells
may be contributing to obesity-related sterile inflammation and insulin resistance. The Journal of Immunology, 2015, 194: 5775–5780.
O
besity is a major public health concern. It is known to be
causally associated with many diseases and, in turn,
impacts negatively on the course of those diseases (1, 2).
There is a marked increase in the prevalence of childhood over-
weight and obesity, with most countries reporting one in four
children being in this category. Childhood obesity tracks strongly
into adulthood (3). There are well-described effects of obesity on
the circulating and adipose tissue (AT)–based immune system.
The net result is sterile inflammation, which appears to underpin
many of the conditions that obesity causes (4–8).
In addition to conventional ab T cells, the immune system contains
populations of MHC-unrestricted T cells with limited TCR diversity.
These include invariant NKT (iNKT) cells, gd T cells, and the focus
of this study, mucosal-associated invariant T (MAIT) cells (9–11).
Human MAIT cells express an invariant Va7.2 TCR chain and high
levels of the NK cell-associated receptor CD161 (10). MAIT cells
recognize bacterial-derived metabolites presented by the MHC-like
molecule MR-1 (12). Compared with other innate T cell populations,
MAIT cells are relatively abundant in human blood (1–8% of T cells,
compared with 0.01–1% for iNKT cells). They are also present in the
intestinal mucosa, liver, lung, and mesenteric lymph nodes (13, 14).
The primary role of MAIT cells in the body appears to be in the
control of bacterial infection, but their role in chronic disease is
emerging with studies showing numerical and functional alterations
in MAIT cells in diseases such as multiple sclerosis and rheumatoid
arthritis (15–17). A recent study by Magalhaes et al. (18) show that
MAIT cells are altered in adult obesity.
In this study, we demonstrate that circulating MAIT cell fre-
quencies are altered in obese individuals with differential effects seen
in adult and pediatric cohorts. In both adults and children, the
proportions of circulating MAIT cells that produced IL-17 were
higher in obese subjects compared with lean subjects. Alterations in
MAIT cells correlated positively with insulin resistance in both
children and adults. We also found that MAIT cells accumulate in
AT, where unlike circulating MAIT cells, they produce IL-10 upon
stimulation. In obese subjects, MAIT cells were reduced in fre-
quency in AT and showed altered cytokine production, with reduced
IL-10 and increased IL-17. Collectively, our findings show that
MAIT cells are affected in number and function by obesity in both
adults and children. They suggest that MAIT cells play a regulatory
role in nonobese individuals, but in obesity display a cytokine profile
associated with several disease states including type 2 diabetes.
Materials and Methods
Subjects
Blood samples were obtained from 65 adult donors, of whom 35 were
categorized as obese, having a body mass index (BMI) of $30, and 60
children, of whom 30 were categorized as obese using the International
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Obesity Taskforce BMI centile charts. Omental AT was obtained from 10
obese adults who were undergoing Roux-en-Y gastric bypass surgery and 8
nonobese adults who were undergoing explorative laparoscopic endos-
copies. Ethical approval for this study was obtained from the Ethics
Committees at St Vincent’s University Hospital Dublin and Our Lady’s
Children’s Hospital Dublin, and all patients or parents of patients gave
written, informed consent. Subject demographics are shown in Table I.
Clinical investigation
A clinical assessment was performed in all participants and in addition to
physical examination included medical history, current health, occurrence
of recent infection, and use of anti-inflammatory medications. In children,
insulin (pmol/l) and glucose (mmol/l) levels weremeasured after a 12-h fast.
Homeostasis model assessment for insulin resistance (HOMA-IR) was
calculated using the following equation: fasting plasma insulin (mU/l) 3
fasting glucose (mmol/l)/22.5. Scores ordinarily range from 0 to 15; higher
scores indicate greater insulin resistance. The degree of insulin resistance
was determined using cutoff of 3.1 because this value was representative of
insulin resistance in both adults and children (19). In adults, hemoglobin
A1c (HbA1c) was measured as a marker for long-term mean plasma
glucose concentration. HbA1c $48 mmol/mol is one of the criteria for the
diagnosis of diabetes.
Flow cytometry
PBMCs were isolated from lean and obese adults and children by Lym-
phoprep density gradient centrifugation (Axis-Shield, Oslo, Norway). AT
stromovascular fraction (SVF) was isolated by mechanically shredding
tissue and digesting with collagenase type II, and CD45+ cells were isolated
from the SVF by magnetic bead separation as described previously (20).
Cells were stained with mAbs specific for CD3, the Va7.2 TCR and
CD161 (to detect MAIT cells), and PD-1 (BD Biosciences, Oxford, U.K.)
and analyzed by flow cytometry using a BD FACSCanto II (BD Bio-
sciences) and FlowJo software (Tree Star, Ashland, OR). Gating strategy
and sample flow plots are shown in Supplemental Fig. 1.
Cytokine production assay
PBMCs or CD45+ AT cells (1 3 106/treatment) were cultured for 18 h in
medium alone or stimulated with either PMA and ionomycin or anti-CD3/
CD28 mAbs in the presence of monensin. For conditioned media experi-
ments, AT explants (nonobese or obese) were cultured in RPMI 1640 for
24 h, the culture media was then filtered and PBMCs from lean donors
were cultured in the AT-conditioned media as described earlier. For insulin
experiments, cell-sorted MAIT cells were cultured in the absence or
presence of 38ng/ml insulin with or without stimulation for 24 h (Levels
based on study by Han and colleagues [21]). Cells were next stained with
mAbs specific for cell-surface markers, fixed using 4% paraformaldehyde,
and permeabilized using 0.2% saponin. Cells were then stained using
mAbs specific for IFN-g, IL-17, and IL-10 (BD Biosciences) and analyzed
by flow cytometry.
Statistical analysis
All analyses were performed using GraphPad Prism 6. Results are expressed
as mean 6 SD. Groups were compared using Student t test or Mann–
Whitney U test as appropriate. Individuals were compared using paired t
test when applicable. Parameter correlation was determined using Pearson
Table I. Patient characteristics
Cohorts Obese Nonobese
Adult n = 30 n = 35
Male, % 40 40
BMI 54 6 9 23 6 7
Age, y 46 6 13 446 14
HbA1c, mmol/mol 44 6 9.8 36.5 6 2.9
Pediatric n = 30 n = 30
Male, % 40 60
BMI Z-score 3.4 6 0.5 0.2 6 1.1
Age, decimal years 13 6 3 12.8 6 3.2
Fasting glucose, mmol/l 5.0 6 0.4 4.8 6 0.4
Fasting insulin, pmol/l 149 6 104 27.5 6 20.20
Surgical n = 10 n = 8
Male, % 40 40
BMI 57 6 6 22 6 1
Age, y 53 6 11 50 6 10
HbA1c 39.4 6 4 N/M
Clinical characteristics of the cohort described in this study. Obese patient in the
surgical cohort underwent Roux-en-Y gastric bypass surgery, and the nonobese con-
trol subjects underwent explorative laparoscopic endoscopies.
FIGURE 1. Circulating MAIT cells are depleted in obese adults and display an alternatively activated phenotype. PBMCs isolated from nonobese and
obese adults were stained for CD161, CD3, and Va7.2 TCR expression. (A and B) Representative flow-cytometry dot plots (A) and scatterplot (B) showing
Va7.2 TCR+ CD161+ CD3+ T cell frequencies in 35 nonobese and 30 obese adults. (C) Scatterplot showing the correlation between MAIT cell frequencies
and BMI in obese adults. (D) Bar graph showing PD-1+ MAIT cell frequencies in nonobese and obese cohorts. (E and F) Bar graphs showing the percentage
of MAIT cells from nonobese and obese subjects that produced IFN-g (E) or IL-17 (F) after stimulation with PMA and ionomycin (n = 15). (G) Bar graph
showing the percentage of MAIT cells from nonobese and obese subjects that produced IL-17 after stimulation with anti-CD3/CD28 mAbs (n = 10). (H)
Scatterplot showing MAIT cell frequencies in obese adults with HbA1c either ,41 (controlled) or .41 (uncontrolled) mmol/mol. (I) Scatterplot showing
MAIT cell frequencies in adults with either an insulin-sensitive (,3.1) or insulin-resistant (.3.1) HOMA-IR. *p , 0.05, **p , 0.01, ***p , 0.001.
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correlation coefficients. The p values are reported with statistical signifi-
cance set at ,0.05.
Results
MAIT cells are altered in adult obesity
We first enumerated circulating MAIT cell frequencies in a cohort
of nonobese and obese adults (Table I), and found that MAIT cell
numbers were lower in the obese subjects compared with the
nonobese subjects (Fig. 1A, 1B). Reduced MAIT cell frequencies
did not correlate with increasing BMI (Fig. 1C). The expression of
PD-1, a marker of late activation and clonal exhaustion, was
expressed by higher frequencies of MAIT cells from obese com-
pared with nonobese subjects (Fig. 1D). Increased expression of
PD-1 suggests that MAIT cells in obese adults may be function-
ally exhausted (22). To investigate this, we next investigated
MAIT cell cytokine production.
Analysis of cytokine production by MAIT cells in PBMCs
revealed that the proportions of circulating MAIT cells that pro-
duced IFN-g were significantly lower in obese compared with lean
adults upon stimulation (Fig. 1E), whereas the proportions that
produced IL-17 were higher (Fig. 1F, 1G). IL-10–producing
MAIT cells were rare or undetectable in the peripheral blood of
both cohorts (data not shown). These data suggest that MAIT cells
via the production of IL-17 may be contributing to obesity-related
morbidities. We next investigated whether alteration in MAIT cell
frequencies were associated with insulin resistance or blood glu-
cose levels. Reduction in MAIT cell frequency was greater in
obese adults with uncontrolled HbA1c (.41 mmol/mol; Fig. 1H)
and insulin resistance (HOMA-IR . 3.1; Fig. 1I).
MAIT cells are enriched in human AT
Omental AT is now established as an important immune site, es-
pecially in the setting of obesity in humans and mice (5). We
assessed human adult AT for the presence of MAIT cells, which
were found to be present at higher frequencies than in matched
peripheral blood from both obese and nonobese subjects (Fig. 2A–
C). Four to 14% of T cells from the AT of nonobese adults was
found to be positive for the Va7.2 TCR and CD161, which is
a 2- to 6-fold increase over MAIT cell frequencies in peripheral
blood. The frequencies of AT MAIT cells were lower in the
obese subjects compared with the nonobese cohort (Fig. 2D).
Upon stimulation of CD45+ SVF cells from AT, significant
proportions of MAIT cells produced IFN-g and IL-17 (Fig. 2E,
2F), and interestingly, a mean of 14.3% of AT MAIT cells pro-
duced IL-10, a cytokine that was not produced by circulating
MAIT cells (Fig. 2G, 2H). When nonobese and obese donors were
compared, the obese cohort showed a reduction in the proportion
of MAIT cells producing IFN-g (Fig. 2E) and IL-10 (Fig. 2G),
with higher proportions producing IL-17 (Fig. 2F).
AT-derived factors alter MAIT cell responses
We next assessed whether soluble factors derived from AT could
influence MAIT cell cytokine production. PBMCs from healthy
nonobese donors were incubated in culture media conditioned with
FIGURE 2. AT MAIT cells are IL-10 producers
and are depleted and alternatively activated in obe-
sity. Isolated CD45+ cells from AT and matched
PBMCs from nonobese and obese adult donors were
stained for CD161, CD3, and Va7.2 TCR expres-
sion. (A) Representative flow-cytometry dot plot
showing MAIT cells in AT. (B and C) Line graph
showing MAIT cell frequencies in blood and
matched AT from 8 nonobese subjects (B) and 10
obese subjects (C). (D) Scatterplot showing the fre-
quencies of MAIT cells in AT from nonobese and
obese donors. (E–G) Bar graphs showing the per-
centages of PMA- and ionomycin-stimulated MAIT
cells that produce IFN-g (E), IL-17 (F), and IL-10
(G). (H) Bar graph comparing IL-10–producing
MAIT cell frequencies in nonobese blood and AT.
(I and J) Bar graphs showing the percentages of
MAIT cells from healthy nonobese donors that
produce IL-17 (I) or IL-10 (J) in the absence or
presence of AT conditioned media. *p , 0.05,
**p , 0.01, ***p , 0.001.
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human AT explants. The proportions of IL-17–producing MAIT
cells were increased in the presence of adipose conditioned me-
dia from both nonobese and, to a greater degree, obese subjects,
compared with controls (Fig. 2I). IL-10–producing MAIT cells
were also induced by culturing PBMCs with nonobese and, to a
lesser extent, obese conditioned media (Fig. 2J). These data sug-
gest that soluble adipose conditioned factors may be, in part, re-
sponsible for the AT MAIT cell cytokine profile. We also in-
vestigated the impact of insulin on MAIT cell production of IL-17
and show no change in response to insulin levels consistent with
the hyperinsulinemic range (Supplemental Fig. 2) (21).
MAIT cell frequency and function is altered in childhood
obesity
Finally, we investigated the frequencies and cytokine profiles of
circulating MAIT cells in a cohort of obese children (mean age 13)
and compared them with age- and sex-matched nonobese peers
(mean age 12.8; Table I). In contrast with the adults, MAIT cell
frequencies were higher in obese compared with nonobese chil-
dren (Fig. 3A, 3B), and they positively correlated with increasing
BMI (Fig. 3C). MAIT cell frequencies declined with age in the
obese cohort, but not the nonobese cohort (Fig. 3D, 3E).
Analysis of cytokine production by unstimulated and stimulated
MAIT cells from nonobese and obese children revealed no dif-
ferences in the percentages that produced IFN-g (Fig. 2F). How-
ever, higher frequencies of IL-17–producing MAIT cells were
found in the obese pediatric cohort compared with nonobese peers
both with and without stimulation (Fig. 2G). Altered MAIT cell
frequency was associated with increased fasting insulin (Fig. 3H)
and was greater in obese children classified as insulin resistant
(Fig. 3I).
Discussion
In this study, we show that MAIT cells are altered in frequency
and function in both adult and childhood obesity. We have pre-
viously reported that another innate T cell population, the iNKT
cell, is altered by obesity in both adults and children (5, 20, 23).
Several reports have described protective or pathogenic roles for
MAIT cells in a number of diseases including multiple sclerosis
and rheumatoid arthritis (15, 16, 24). We found that in obese
adults, MAIT cells are reduced in the circulation, and this was
associated with an increase in the frequency of IL-17–producing
MAIT cells. The change in MAIT cell frequency was greater in
obese adults with uncontrolled HbA1c. MAIT cell frequencies
were also significantly lower in adults classified as insulin resis-
tant by HOMA-IR. These data suggest that changes in MAIT cell
frequencies and functions may be contributing to insulin resis-
tance and type 2 diabetes mellitus (T2DM). These data are sup-
ported by a recent study by Magalhaes et al. (18), who also report
alteration in MAIT cell frequency and function in obese adults
FIGURE 3. Circulating MAIT cells are ex-
panded in childhood obesity and display increased
IL-17 production. PBMCs from nonobese and
obese children were stained for CD161, CD3, and
Va7.2 TCR expression. (A) Representative flow-
cytometry dot plots showing Va7.2 TCR+ CD161+
CD3+ T cell frequencies in nonobese and obese
pediatric cohorts. (B) Scatterplot showing the fre-
quencies of MAIT cells in 30 nonobese and 30
obese children. (C) Scatterplot showing the corre-
lation between MAIT cell frequency and BMI
in a cohort of nonobese and obese children. (D and
E) Scatterplots showing the correlation between
MAIT cell frequency and age in a cohort of non-
obese (D) and obese (E) children. (F and G) Bar
graphs showing the percentage of IFN-g– (F) or
IL-17–producing (G) MAIT cells in nonobese and
obese pediatric cohorts either unstimulated or
stimulated with PMA/ionomycin (n = 10). (H)
Scatterplot showing correlation between MAIT
cell frequency and fasting insulin levels. (I) Scat-
terplot showing MAIT cell frequency in obese
children with either an insulin-sensitive (,3.1) or
insulin-resistant (.3.1) HOMA-IR. *p , 0.05,
**p , 0.01, ***p , 0.001.
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with T2DM. IL-17 signature cytokines have been shown to induce
insulin resistance in adipocytes, skeletal muscle cells, and hep-
atocytes (25–27). Our demonstration that MAIT cells from obese
subjects are significant producers of IL-17 may represent another
mechanistic link between obesity and insulin resistance.
Previously, we reported that iNKT cells are abundant in human
AT and are important regulators of AT homeostasis (15). In this
study, we show that MAIT cells are also expanded in human AT.
Similar to iNKT cells, MAIT cell frequencies were lower in AT
from obese compared with lean subjects. Although previous
studies have reported that peripheral MAIT cells produce very
little or no IL-10 (14), our data show that significant proportions of
AT-resident MAIT cells can produce IL-10, suggesting a possible
regulatory role for these cells in human AT. Similar tissue-specific
cytokine production has been reported for AT iNKT cells, which
produce IL-10 almost exclusively in the AT (5, 14, 28). The re-
duction in IL-10–producing MAIT cells and an increase in the
frequency of IL-17–producing MAIT cells in obese AT further
supports the concept of an alternatively activated MAIT cell in
obesity. Again, the alternative activation of MAIT cells in AT may
contribute to morbidity, because increased IL-17 production in AT
has been linked to insulin resistance in adipocytes, hepatocytes,
and muscle cells (25, 26).
To further investigate a role for MAIT cells in obesity-driven
insulin resistance, we examined MAIT cells in a cohort of obese
children and show that they are expanded when compared with
nonobese peers. The discordance between MAIT cell frequencies
in obese adults and children contrasts with our recent finding that
iNKT cells are depleted in both obese adults and children, when
compared with their lean peers (23). MAIT cells are few in number
in cord blood and neonates, and absent in germ-free mice, sug-
gesting their development requires the presence of gut microflora
(29). Obesity is associated with alterations of the composition and
functional properties of the gut microbiota, which play a role in
the regulation of bodyweight and inflammatory status (30, 31). It
is possible that an altered microbiome in obese children is con-
tributing to the observed increase in MAIT cells (32). Interest-
ingly, MAIT cell frequencies in obese children declined as children
tracked toward adulthood; this reduction was not observed in the
nonobese cohort, suggesting MAIT cell frequency ultimately
declines with obesity.
Consistent with our finding in obese adults, there was an in-
crease in the frequency of IL-17–producing MAIT cells in obese
children. Proinflammatory cytokine profiles have been previ-
ously described in obese children (23, 33, 34), and the increased
IL-17 production by MAIT cells from obese children may con-
tribute to the observed inflammatory profile and increased risk
for development of obesity-related diseases such as T2DM.
Unlike our adult population, the majority of whom are insulin
resistant and have T2DM, none of the obese children in this
study has developed T2DM, but significant proportions are
hyperinsulinemic and insulin resistant. Alterations in MAIT cell
frequency correlated with increased fasting insulin and were
greater in insulin-resistant children, again implicating MAIT
cells in insulin resistance. We did investigate the impact of in-
sulin on MAIT cell production of IL-17 but did not observe an
effect. This study is observational, and causality will require
a more detailed understanding of the role of the MAIT cell in
insulin resistance.
In this study, we have demonstrated that MAIT cells are altered
in both adult and childhood obesity. AT MAIT cells are a novel
subset of IL-10–producing cells, which, in turn, are impacted
on by obesity. Collectively, our data suggest a possible role for
MAIT cells in insulin resistance and the development of T2DM.
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